Repligen (RGEN)
Supplies filtration, chromatography, analytics, and protein technologies for biologics manufacturers and CDMOs.
$182.54
vs last close−4.21 (−2.26%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 117.94% | 66.56M shares | |
|---|---|---|---|
| 497 holders · as of Jun 30, 2026 | |||
| Insiders | 6.88% | 3.88M shares | |
| 16 holders · as of Sep 22, 2026 | |||
| Adds to | 124.82% | ||
56.44M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 124.82%; nothing is left for Other.
13F, as of Jun 30, 2026
497 holders · 66.56M shares · 100 new positions · 280 increased · 141 reduced · 60 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 5.38M | 9.54% | −608.1K | Aug 7, 2026 |
| FMR LLC | 3.33M | 5.89% | +439.9K | Aug 13, 2026 |
| United Capital Financial Advisers, LLC | 2.79M | 4.94% | +16.7K | Aug 17, 2026 |
| Vanguard Capital Management LLC | 2.41M | 4.27% | +14.7K | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 2.31M | 4.10% | +7.7K | Aug 13, 2026 |
| Maverick Capital Ltd | 1.98M | 3.52% | +465.7K | Aug 14, 2026 |
| State Street Corp | 1.80M | 3.19% | +23.2K | Aug 7, 2026 |
| Price T Rowe Associates Inc /MD/ | 1.75M | 3.10% | −3.13M | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 9.30% | 5.20M | 13G | Apr 24, 2025 |
| T. Rowe Price Associates, Inc. | 8.20% | 4.60M | 13G | Feb 17, 2026 |
| FMR LLC | 5.10% | 2.89M | 13G | Feb 5, 2026 |
| Vanguard Capital Management | 5.00% | 2.83M | 13G | Jul 31, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 21, 2026 | Olivier Loeillotdirector, officer: Chief Executive Officer | Sale | 5,426 | $180.00 | 48,369 |
| Sep 4, 2026 | Olivier Loeillotdirector, officer: Chief Executive Officer | Sale | 3,035 | $165.90 | 48,369 |
| Aug 20, 2026 | Olivier Loeillotdirector, officer: Chief Executive Officer | Sale | 5,426 | $180.00 | 54,246 |
| Jul 16, 2026 | Jason K. Garlandofficer: CFO | Sale | 530 | $150.00 | 18,829 |
| Jun 25, 2026 | Jason K. Garlandofficer: CFO | Sale | 733 | $145.00 | 19,359 |
| Apr 21, 2026 | Olivier Loeillotdirector, officer: Chief Executive Officer | Sale | 3,832 | $140.00 | 54,246 |
| Dec 17, 2025 | Karen A. Dawesdirector | Sale | 275 | $161.00 | 91,821 |
| Nov 25, 2025 | Olivier Loeillotdirector, officer: Chief Executive Officer | Sale | 7,041 | $170.00 | 35,898 |
| Nov 18, 2025 | James Bylundofficer: Chief Operating Officer | Sale | 2,191 | $151.21 | 21,520 |
| Nov 13, 2025 | Anthony Huntdirector | Sale · 7 lots | 20,000 | $154.61 | 80,743 |
House and Senate disclosures
Not reported.